4.7 Article

Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 16, Issue 10, Pages 5398-5404

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.04.027

Keywords

sulfonyl pyrrolidine derivatives; synthesis; MMP-2 inhibitors; IC50.

Ask authors/readers for more resources

A series of novel sulfonyl pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. Compounds 6a-d were more potent MMP-2 inhibitors than the positive control LY52. The structure-activity relationships were also briefly discussed. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Chemistry, Medicinal

Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery

Yongzhen Guo, Xuben Hou, Hao Fang

Summary: Benzimidazole, an aromatic bicyclic heterocycle, is considered valuable in medicinal chemistry and is found in many marketed drugs and natural products that fight various diseases. This review focuses on the pharmacological applications of these drugs, especially anticancer agents, from 2014 to 2019, showcasing their biological activities at targets.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)

Article Medicine, Research & Experimental

A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-κB pathway

Wanzhen Lu, Chan Yang, Xinfeng Xu, Chen Chen, Xuben Hou, Hao Fang, Shuwen Liu

Summary: The synthesized HDAC I inhibitor CC-4a was found to reactivate latent HIV-1 at the protein and gene levels with low cytotoxicity and induced apoptosis in HIV-1 infected cell models. CC-4a also showed a synergistic activation effect with prostratin without triggering global T cell activation and down-regulated the expressions of CCR5 and CD4. Furthermore, CC-4a together with antiviral drugs antagonized HIV-1 without mutual interference by enhancing histone acetylation and activating the NF-kappa B pathway.

LIFE SCIENCES (2021)

Review Pharmacology & Pharmacy

Strategies to overcome drug resistance using SHP2 inhibitors

Meng Liu, Shan Gao, Reham M. Elhassan, Xuben Hou, Hao Fang

Summary: SHP2, encoded by PTPN11, is widely recognized as a carcinogenic phosphatase and a promising anti-cancer drug target. It regulates multiple signaling pathways and immune cell function, and has shown therapeutic potential in overcoming drug resistance in cancer treatment.

ACTA PHARMACEUTICA SINICA B (2021)

Review Biochemistry & Molecular Biology

Boronate-Based Fluorescent Probes as a Prominent Tool for H2O2 Sensing and Recognition

Ling Wang, Xuben Hou, Hao Fang, Xinying Yang

Summary: Fluorescent probes have been widely used as important tools for detecting H2O2 to reflect the physiological and pathological conditions of biological systems, with boronate ester and boronic acid groups serving as sensitive responsive parts in these probes. This review summarizes fluorescent probes based on boronate ester/boronic acid groups reported from 2012 to 2020, and classifies the fluorophores into six categories to elaborate the design strategy and systematic performance comprehensively.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors

Tao Liang, Junxin Xue, Zefu Yao, Yang Ye, Xinying Yang, Xuben Hou, Hao Fang

Summary: Compound 71, a new HDAC6 inhibitor, showed superior selectivity and activity, with potential application in cancer therapy.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell sorting and early cancer diagnosis

Tao Liang, Jia Li, Yi Zhou, Xuben Hou, Xinying Yang, Hao Fang

Summary: BPFP1 is a new tool for Bcl-2 protein quantification, carcinoma cell visualization, and cell sorting. It can fluorescently label carcinoma cells by binding to overexpressed Bcl-2 protein and distinguish carcinoma cells from normal tissue cells based on the different Bcl-2 protein expression levels.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity

Chen Chen, Xue Li, Huajun Zhao, Meng Liu, Jintong Du, Jian Zhang, Xinying Yang, Xuben Hou, Hao Fang

Summary: The combined use of a DNA minor groove binder and a histone deacetylase (HDAC) inhibitor has shown a synergistic antiproliferation effect. A new series of benzimidazole-hydroxamate hybrids were designed and synthesized to target both DNA minor groove and HDAC. The most active compounds 9k and 9l not only exhibited improved HDAC inhibitory activities but also showed potent antiproliferation activities against tumor cells. Importantly, these compounds demonstrated good in vivo antitumor efficacies and reshaped the tumor immune microenvironment by promoting antigen presentation, activating T cells, and polarizing tumor-infiltrating macrophages with antitumor activity.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Chemistry, Medicinal

Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery

Reham M. Elhassan, Xuben Hou, Hao Fang

Summary: The PTP family plays a crucial role in human diseases, with traditional active-site inhibitors facing limitations. Allosteric modulation has emerged as a promising approach in drug development, leading to a growing interest in novel allosteric PTPs inhibitors in recent years.

MEDICINAL RESEARCH REVIEWS (2022)

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors

Xiao Liang, Xue Li, Zhiyuan Zhao, Yiming Nie, Zefu Yao, Wandi Ren, Xinying Yang, Xuben Hou, Hao Fang

Summary: In this study, a series of hydantoin derivatives were designed and synthesized as novel Mcl-1 inhibitors. Compound M23 and M24 showed good binding affinities against Mcl-1. Additionally, these compounds exhibited good selectivity and stability.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

Yuanju Zhu, Jay Zhang, Feng Min, Xinying Yang, Li Li, Yan Zhang, Xuben Hou, Hao Fang

Summary: The farnesoid X receptor (FXR) is a bile acid activated transcription factor and is involved in important metabolic processes. It is considered a promising therapeutic target for nonalcoholic steatohepatitis (NASH). A series of new FXR agonists were designed in this study, with five compounds showing better activity than the widely used GW4064. The most potent compound S5 also had superior pharmacokinetic profile and in vivo potency compared to the lead compound.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Discovery of semisynthetic celastrol derivatives exhibiting potent anti-ovarian cancer stem cell activity and STAT3 inhibition

Na Li, Chaobo Li, Juan Zhang, Qian Jiang, Zhaoxue Wang, Shaozhen Nie, Zhenzhen Gao, Guangyao Li, Hao Fang, Shaoda Ren, Xiaojing Li

Summary: Ovarian cancer is characterized by its high mortality rate due to the presence of cancer stem cells, which lead to treatment recurrence and metastasis. A study found that the celastrol derivative 6c showed potential inhibition against ovarian cancer cells and exhibited anti-cancer stem cell effects by inhibiting sphere formation and regulating cell surface markers. Furthermore, compound 6c also attenuated the expression of the STAT3 pathway, suggesting its role in inhibiting ovarian cancer cells.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Article Chemistry, Multidisciplinary

Development of QSRR model for hydroxamic acids using PCA-GA-BP algorithm incorporated with molecular interaction-based features

Yiming Nie, Jia Li, Xinying Yang, Xuben Hou, Hao Fang

Summary: This study used the inhibitory activity of hydroxamic acid against HDACs for QSRR research and employed PCA for dimension reduction of descriptors and GA-BP algorithm for model development. The results showed that incorporating molecular interaction-based features significantly improved the accuracy of the QSRR model.

FRONTIERS IN CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity

Meng Liu, Shan Gao, Tao Liang, Xueting Qiu, Xinying Yang, Hao Fang, Xuben Hou

Summary: This study observed a synergistic antiproliferation effect of SHP2 inhibitor and HDAC inhibitor and designed a series of SHP2/HDAC dual inhibitors. Compound 8t showed excellent inhibitory activities against SHP2 and HDAC1 and exhibited improved antitumor activities. In addition, compound 8t could trigger antitumor immunity by activating T cells, enhancing antigen presentation, and promoting cytokine secretion.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Oncology

PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer

Xuben Hou, Jintong Du, Hao Fang

Summary: PTPRO may have oncogenic roles in specific cancer types such as pancreatic cancer, blood cancer, and breast cancer. Inhibition of PTPRO can suppress the proliferative abilities of tumor cells, while PTPRO expression promotes immune cell infiltration in pancreatic cancer.

JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Recent Development of Novel HDAC6 Isoform-selective Inhibitors

Yunpeng Zhao, Tao Liang, Xuben Hou, Hao Fang

Summary: Histone deacetylation plays crucial roles in chromatin remodeling and gene expression, and aberrant modification can lead to various diseases. HDAC6, a critical member of the HDAC family, serves as a key modulator in many physiological processes, and abnormal expression is linked to cancer, neurodegeneration, and other diseases. Recent advances have been made in the physiological functions, protein structure, and development of HDAC6 selective inhibitors.

CURRENT MEDICINAL CHEMISTRY (2021)

No Data Available